FOLH1 and thyroid cancer: Despite its name, PSMA is not limited to the prostate; it has been reported to be expressed in the neovasculature of a variety of solid tumors, and enhanced uptake of 68Ga-PSMA PET/CT has been demonstrated in a variety of non-prostatic malignancies, including thyroid cancer [16,17].